AORT insider files Form 144 to sell 23,356 shares on NYSE

Rhea-AI Filing Summary

Artivion, Inc. (AORT) has a Form 144 notice reporting a proposed sale of 23,356 common shares with an aggregate market value of $1,004,605.97. The sale is listed as occurring approximately on 08/12/2025 on the NYSE through Morgan Stanley Smith Barney LLC.

The filing shows how the shares were acquired: 6,381 as restricted stock on 02/19/2019 and 16,975 via a stock option exercise on 08/12/2025 paid in cash. The form also discloses multiple insider sales in May 2025 by JEAN F HOLLOWAY, including transactions on 05/21/2025 and 05/27/2025, each with listed share amounts and gross proceeds. The filer affirms no undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Routine Form 144 indicating an insider sale of 23,356 shares valued at about $1.0M; transactions disclosed with acquisition dates.

The filing documents a proposed sale of 23,356 common shares on the NYSE with an aggregate market value of $1,004,605.97. Acquisition details are explicit: 6,381 restricted shares from 02/19/2019 and 16,975 from a 08/12/2025 stock option exercise paid in cash. Recent dispositions by JEAN F HOLLOWAY in May 2025 are itemized with share counts and gross proceeds. From a market-impact perspective, the filing is a standard insider disclosure with no additional financial metrics provided in this document.

Corporate Governance Expert

TL;DR: Disclosure meets Rule 144 requirements; includes acquisition provenance and a statement negating undisclosed material information.

The notice provides the required provenance for the securities to be sold and identifies the broker and proposed exchange. It lists both restricted stock and option-exercise origins and includes a signed representation that the filer does not possess undisclosed material adverse information. The document is procedural and compliant in form; it does not contain operational or governance changes beyond the securities disposition details provided.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	23356	1004605.97	47183658	08/12/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/19/2019	Restricted Stock	Issuer			6381	02/19/2019	Not Applicable
Common	08/12/2025	Stock Option Exercise	Issuer			16975	08/12/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JEAN F HOLLOWAY 1655 ROBERTS BLVD NW KENNESAW GA 30144	Common	05/27/2025	3501	101529.00
JEAN F HOLLOWAY 1655 ROBERTS BLVD NW KENNESAW GA 30144	Common	05/27/2025	2369	68701.00
JEAN F HOLLOWAY 1655 ROBERTS BLVD NW KENNESAW GA 30144	Common	05/27/2025	1184	34336.00
JEAN F HOLLOWAY 1655 ROBERTS BLVD NW KENNESAW GA 30144	Common	05/27/2025	1694	49126.00
JEAN F HOLLOWAY 1655 ROBERTS BLVD NW KENNESAW GA 30144	Common	05/21/2025	9926	287854.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Artivion (AORT) report in this Form 144?

The Form 144 reports a proposed sale of 23,356 common shares with an aggregate market value of $1,004,605.97 to be sold on the NYSE.

When is the proposed sale of AORT shares scheduled?

The filing lists an approximate date of sale of 08/12/2025 for the 23,356 shares.

How were the shares being sold acquired according to the filing?

The filing shows 6,381 shares acquired as restricted stock on 02/19/2019 and 16,975 shares acquired by stock option exercise on 08/12/2025 paid in cash.

Were there recent insider sales disclosed in the filing for AORT?

Yes. The filing lists multiple sales by JEAN F HOLLOWAY in May 2025, including transactions on 05/21/2025 and 05/27/2025 with share amounts and gross proceeds shown.

Which broker and venue are named for the proposed sale?

The broker is listed as Morgan Stanley Smith Barney LLC and the exchange is the NYSE.